Diabetes
Researchers from the United States and United Kingdom describe findings in diabetes studies
Published in Obesity and Diabetes Week, August 28th, 2006
Study 1: Oral hypoglycemic agents or intensive insulin therapy can provide glycemic control for many diabetic patients.
According to a recent review from the United States, "The risk of developing cardiovascular disease (CVD) is higher and the prognosis poorer for diabetic than for non-diabetic individuals. Diabetic dyslipidaemia is characterized by hypertriglyceridaemia, low levels of high-density lipoprotein cholesterol (HDL-C) and the presence of small, dense low-density lipoprotein (LDL) particles."
S.L. Schwartz at the Diabetes &...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Brain-derived neurotrophic factor is higher and linked to obesity in female diabetics - Diabetes Prevention
Diet and exercise regimen can reverse metabolic syndrome in overweight children - Diabetes Therapy
Chiglitazar may offer better lipid homeostasis than selective PPAR gamma agonists in diabetes - Endocrinology
Improved body weight and AMP-activated kinase activity may be leptin dependent in mouse model - Endocrinology
Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin - Acute Myeloid Leukemia
ChemGenex publishes two new clinical studies supporting Ceflatonin beyond CML to other leukemias - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
